Physician profile
Mark A Decotiis
NPI 1851360036
$7,146.74
in general payments reported to CMS, 2019-2025
25 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $859 · 2021: $321 · 2022: $662 · 2023: $1,440 · 2024: $1,426 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840 · Travel and Lodging: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,840.25 |
| Travel and Lodging | $1,105.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $1,686.21 | 2019-2023 | Minimally Invasive Bunion Plate, Left, 3.4mm X 3.0mm X 10mm Two-Step Hammer Toe Implant, 2.0mm X 26mm Tiger Cannulated Screw |
| Treace Medical Concepts, INC. | $1,519.57 | 2024-2025 | |
| Stryker Corporation | $1,411.43 | 2022-2025 | Augment Injectable, Ortholoc 3di, Variax |
| Musculoskeletal Transplant Foundation INC. | $394.00 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $385.46 | 2020-2025 | Jublia |
| Bioventus LLC | $220.46 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $211.48 | 2022 | |
| Smith+Nephew, INC. | $177.66 | 2019-2025 | Collagenase Santyl |
| Abbott Laboratories | $148.84 | 2023 | Proclaim |
| Kerecis Limited | $136.77 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Seapearl East, INC | $133.47 | 2025 | |
| Sandoz INC. | $117.10 | 2019-2020 | |
| Horizon Therapeutics Plc | $103.51 | 2019-2020 | |
| Cardiovascular Systems INC. | $96.82 | 2021 | |
| Integra Lifesciences Corporation | $87.08 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $86.06 | 2023 | Dynanail Mini, Eclipse, Morphix |
| Organogenesis INC. | $61.51 | 2019-2022 | |
| Novastep INC. | $41.38 | 2022-2023 | Creed Ortholocent Implants |
| Hydrofera LLC | $32.39 | 2021-2023 | Hydrofera Blue |
| Bone Support INC. | $22.00 | 2025 | Ceramentbone Void Filler, Cerament G |
| Tactile Systems Technology INC | $18.23 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.99 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $14.82 | 2025 | |
| Paragon 28, INC. | $13.81 | 2024 | |
| Misonix INC | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Decotiis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.